```html

Kernicterus (Neurologic Symptoms of Severe Jaundice)

What is Kernicterus (Neurologic Symptoms of Severe Jaundice)?

Kernicterus is a rare but serious form of brain damage that occurs when very high levels of unconjugated bilirubin (the yellow pigment that causes jaundice) cross the immature blood‑brain barrier of a newborn and deposit in the basal ganglia and brainstem. The condition produces a spectrum of neurologic signs—ranging from lethargy and poor feeding to abnormal muscle tone, seizures, and permanent cerebral palsy.

Although the term “kernicterus” historically described the permanent, irreversible brain injury, many clinicians now use it to refer to both acute neurologic symptoms of severe jaundice and the chronic sequelae that follow.

Sources: Mayo Clinic; CDC.

Common Causes

In most cases, kernicterus results from an underlying condition that leads to excessive bilirubin production, impaired bilirubin conjugation, or reduced bilirubin elimination. The most frequent culprits include:

• Hemolytic disease of the newborn (HDN) – maternal‑fetal blood group incompatibility (e.g., Rh or ABO).
• G6PD deficiency – an inherited enzyme defect that makes red blood cells fragile.
• Hereditary spherocytosis – abnormal red‑cell membranes cause chronic hemolysis.
• Crigler‑Najjar syndrome type I – a rare genetic loss of the enzyme UDP‑glucuronosyltransferase.
• Breast‑feeding jaundice – inadequate intake during the first days of life.
• Breast‑milk jaundice – substances in breast milk that increase enterohepatic circulation of bilirubin.
• Prematurity – immature liver enzymes and a more permeable blood‑brain barrier.
• Sepsis or severe infections – can increase hemolysis and impair hepatic function.
• Medications that displace bilirubin – e.g., sulfonamides, ceftriaxone.
• Congenital infections – such as cytomegalovirus (CMV) or toxoplasmosis.

Associated Symptoms

Kernicterus does not develop in isolation; clinicians look for a cluster of findings that signal the bilirubin level is dangerously high.

• Extreme jaundice (skin and sclera appear deep yellow‑orange).
• Lethargy or difficulty waking the infant.
• Poor feeding or vomiting.
• Hypotonia (floppy limbs) progressing to hypertonia (muscle rigidity).
• High‑pitched cry or abnormal crying pattern.
• Apnea or irregular breathing.
• Seizures (often focal at first).
• Auditory dysfunction – infants may not respond to sounds.
• Later‑onset movement disorders (e.g., athetoid cerebral palsy).

When to See a Doctor

Newborn jaundice is common, but the following situations require immediate medical evaluation:

• Bright yellow or orange discoloration that spreads to the chest, abdomen, or limbs.
• Jaundice persisting beyond 14 days in term infants or beyond 5 days in preterm infants.
• Any change in the baby’s level of alertness, feeding, or muscle tone.
• Episodes of breathing difficulty, apnea, or seizures.
• Signs of dehydration (dry mouth, sunken fontanelle, reduced urine output).
• Family history of hemolytic disease, G6PD deficiency, or bilirubin‑metabolism disorders.

When in doubt, call your pediatrician or go to the nearest emergency department; early intervention can prevent permanent injury.

Diagnosis

Diagnosing kernicterus involves a combination of clinical assessment and laboratory testing.

1. Physical exam

• Assessment of skin and scleral coloration.
• Neurologic exam for tone, reflexes, and responsiveness.

2. Serum bilirubin measurement

• Total serum bilirubin (TSB) – values >20 mg/dL (≈340 µmol/L) in term infants or lower thresholds in preterms raise alarm.
• Distinguish between unconjugated (indirect) and conjugated (direct) fractions.

3. Blood typing & Coombs test

• Identify maternal‑fetal blood group incompatibility.

4. Hemolysis work‑up

• Complete blood count, reticulocyte count, G6PD assay, peripheral smear.

5. Imaging & neuro‑diagnostic studies (if neurologic signs present)

• Transcranial ultrasound or MRI – may show basal‑ganglia hyperintensity.
• Auditory brain‑stem response (ABR) testing for hearing loss.

6. Genetic testing (select cases)

• Testing for Crigler‑Najjar, UDP‑glucuronosyltransferase (UGT1A1) variants.

All diagnostic steps should be documented and interpreted in the context of the newborn’s age, gestational age, and risk factors.

Treatment Options

The primary goal is to rapidly reduce serum bilirubin and prevent further brain exposure.

1. Phototherapy

• Blue‑green (460 nm) light converts unconjugated bilirubin into water‑soluble isomers that can be excreted without conjugation.
• Intensive phototherapy (double‑surface or fiber‑optic blankets) is used when TSB exceeds treatment thresholds defined by the American Academy of Pediatrics (AAP) nomograms.

2. Exchange transfusion

• Indicated when bilirubin levels are critically high (usually >30 mg/dL in term infants) or when neurologic symptoms appear despite maximal phototherapy.
• Rapidly removes bilirubin‑laden red cells and replaces them with donor blood, lowering bilirubin by 50‑80 % in one procedure.

3. Intravenous immunoglobulin (IVIG)

• Useful in hemolytic disease of the newborn; it blocks Fc receptors and reduces hemolysis, thereby decreasing bilirubin production.

4. Medications

• Phenobarbital can induce hepatic enzymes in chronic conditions (e.g., Crigler‑Najjar type II) but is not suitable for acute kernicterus.

5. Supportive care

• Optimal feeding—preferably breast‑milk or formula—to promote stooling and bilirubin excretion.
• Maintain hydration and electrolytes.
• Monitor for seizures; treat with phenobarbital or benzodiazepines as needed.
• Early physiotherapy for infants who develop tone abnormalities.

6. Long‑term management

• Audiology follow‑up for sensorineural hearing loss.
• Developmental assessments and early intervention services.
• Consider chronic phototherapy or liver transplantation in rare intractable metabolic disorders.

Prevention Tips

Many cases of severe neonatal jaundice are preventable with routine care and early detection.

• Universal newborn screening for bilirubin levels before discharge (often using transcutaneous bilirubinometers).
• Scheduled follow‑up visits for the first week of life, especially for premature infants or those with risk factors.
• Encourage frequent feeding—aim for 8–12 feeds per 24 h—to enhance stool output.
• Educate parents about the appearance of jaundice and warning signs.
• Identify and manage hemolytic risk factors (e.g., give Rh immunoglobulin to Rh‑negative mothers).
• Avoid medications that displace bilirubin in newborns (e.g., ceftriaxone) unless absolutely necessary.
• For infants with known metabolic disorders, initiate prophylactic phototherapy soon after birth.
• Maintain optimal temperature and avoid prolonged fasting in the NICU.

Emergency Warning Signs

If any of the following occurs, seek emergency care immediately (call 911 or go to the nearest ER):

• Sudden deepening of yellow skin or eyes, especially spreading to the abdomen, arms, or legs.
• Extreme sleepiness, inability to wake the baby for feeding.
• Persistent high‑pitched cry or complete loss of cry.
• Seizure activity (jerking movements, stare, loss of consciousness).
• Apnea episodes or irregular breathing.
• Rapidly increasing head circumference or bulging fontanelle.
• Unusual stiffness, floppiness, or uncontrolled movements.

---

Early recognition and treatment of severe jaundice are critical to prevent the devastating neurologic consequences of kernicterus. Parents and caregivers should be proactive in monitoring newborn skin color, feeding patterns, and responsiveness, and should never hesitate to contact a healthcare professional when concerns arise.

References:

1. Mayo Clinic. Kernicterus. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. Kernicterus and Severe Neonatal Jaundice. https://www.cdc.gov
3. American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022.
4. World Health Organization. Neonatal Jaundice and Its Management. WHO Guidelines, 2021.
5. Cleveland Clinic. Kernicterus: What Parents Should Know. https://my.clevelandclinic.org

```